Clarendon Private LLC acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 2,584 shares of the healthcare conglomerate’s stock, valued at approximately $1,307,000. UnitedHealth Group comprises about 1.4% of Clarendon Private LLC’s investment portfolio, making the stock its 14th biggest position.
Several other large investors have also bought and sold shares of UNH. Crescent Grove Advisors LLC boosted its position in shares of UnitedHealth Group by 5.5% during the fourth quarter. Crescent Grove Advisors LLC now owns 1,251 shares of the healthcare conglomerate’s stock valued at $633,000 after buying an additional 65 shares during the last quarter. KFG Wealth Management LLC raised its holdings in shares of UnitedHealth Group by 8.6% during the fourth quarter. KFG Wealth Management LLC now owns 2,036 shares of the healthcare conglomerate’s stock valued at $1,030,000 after purchasing an additional 162 shares during the last quarter. Jamison Private Wealth Management Inc. boosted its holdings in UnitedHealth Group by 11.9% in the fourth quarter. Jamison Private Wealth Management Inc. now owns 1,371 shares of the healthcare conglomerate’s stock worth $693,000 after purchasing an additional 146 shares during the last quarter. Blue Square Asset Management LLC raised its stake in UnitedHealth Group by 2.5% during the 4th quarter. Blue Square Asset Management LLC now owns 5,245 shares of the healthcare conglomerate’s stock valued at $2,653,000 after buying an additional 127 shares during the last quarter. Finally, Archford Capital Strategies LLC boosted its stake in shares of UnitedHealth Group by 1.0% in the 4th quarter. Archford Capital Strategies LLC now owns 8,939 shares of the healthcare conglomerate’s stock worth $4,522,000 after buying an additional 86 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at UnitedHealth Group
In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Company insiders own 0.33% of the company’s stock.
UnitedHealth Group Trading Up 0.5 %
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the firm posted $5.83 earnings per share. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.74 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.58%. UnitedHealth Group’s payout ratio is currently 54.19%.
Wall Street Analysts Forecast Growth
UNH has been the topic of several research reports. UBS Group dropped their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research note on Friday, January 10th. Morgan Stanley decreased their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Finally, Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $627.74.
View Our Latest Analysis on UNH
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- Transportation Stocks Investing
- MP Materials: Rare Earth Elements Powering the EV Boom
- Most active stocks: Dollar volume vs share volume
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- Stock Average Calculator
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.